Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 290.35 billion. The enterprise value is 327.41 billion.

Market Cap	290.35B
Enterprise Value	327.41B

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.49B

Valuation Ratios

The trailing PE ratio is 12.98 and the forward PE ratio is 9.15.

PE Ratio	12.98
Forward PE	9.15
PS Ratio	3.35
PB Ratio	4.34
P/TBV Ratio	17.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.27, with an EV/FCF ratio of 16.31.

EV / Earnings	14.63
EV / Sales	3.73
EV / EBITDA	8.27
EV / EBIT	9.90
EV / FCF	16.31

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio	1.42
Quick Ratio	0.82
Debt / Equity	0.72
Debt / EBITDA	1.23
Debt / FCF	2.40
Interest Coverage	18.77

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.04%.

Return on Equity (ROE)	35.42%
Return on Assets (ROA)	13.01%
Return on Invested Capital (ROIC)	18.04%
Return on Capital Employed (ROCE)	26.18%
Revenue Per Employee	1.17M
Profits Per Employee	302,371
Employee Count	75,000
Asset Turnover	0.55
Inventory Turnover	2.20

Taxes

In the past 12 months, Merck & Co. has paid 3.74 billion in taxes.

Income Tax	3.74B
Effective Tax Rate	14.32%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	18.54
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.26
Average Volume (20 Days)	10,743

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.82

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 86.76 billion and earned 22.38 billion in profits. Earnings per share was 8.84.

Revenue	86.76B
Gross Profit	67.16B
Operating Income	32.66B
Pretax Income	26.14B
Net Income	22.38B
EBITDA	38.64B
EBIT	32.66B
Earnings Per Share (EPS)	8.84

Full Income Statement

Balance Sheet

The company has 11.76 billion in cash and 48.28 billion in debt, giving a net cash position of -36.52 billion.

Cash & Cash Equivalents	11.76B
Total Debt	48.28B
Net Cash	-36.52B
Net Cash Per Share	n/a
Equity (Book Value)	66.91B
Book Value Per Share	26.69
Working Capital	15.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.28 billion and capital expenditures -5.20 billion, giving a free cash flow of 20.08 billion.

Operating Cash Flow	25.28B
Capital Expenditures	-5.20B
Free Cash Flow	20.08B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.41%, with operating and profit margins of 37.64% and 25.79%.

Gross Margin	77.41%
Operating Margin	37.64%
Pretax Margin	30.12%
Profit Margin	25.79%
EBITDA Margin	44.53%
EBIT Margin	37.64%
FCF Margin	23.14%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.95%
Buyback Yield	0.77%
Shareholder Yield	n/a
Earnings Yield	7.71%
FCF Yield	6.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.33 and a Piotroski F-Score of 6.

Altman Z-Score	4.33
Piotroski F-Score	6